Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Hepatitis
New hepatitis study findings have been reported from Center for Satellite Applications and Research
March 11th, 2009
"The study of host-virus interactions that determine liver disease pathogenesis and outcome of infection have been key issues of interest in the field of viral hepatitis," scientists in Singapore, Singapore report. "It is generally accepted that infection with noncytopathic viruses, such as HBV and HCV, triggers the activation of immunological events involving virus-specific cytotoxic T lymphocytes (CTLs), which helps to control viral replication but at the same time causes liver inflammation and damage due to the recruitment of antigen-nonspecific inflammatory cells. However, not much is known regarding the factors modulating intrahepatic CTL function or the complex...
Source: Vaccine Weekly (2009-03-11)
|
